The mentioned hypothesis is supported by the fact that the drug etomoxir, an inhibitor of β-oxidation, shows anti-cancer effects47 and that expression of carnitine palmitoyltransferase 1C (CPT1C) involved in the carnitine shuttle, promotes cell survival and tumor growth48. Here, CPT1C is linked to neoplasm.